Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1948 2
1958 1
1964 1
1965 1
1967 1
1969 3
1973 2
1974 1
1975 2
1976 2
1977 3
1978 2
1979 2
1980 4
1981 3
1982 9
1983 16
1984 1
1985 10
1986 10
1987 16
1988 17
1989 15
1990 18
1991 22
1992 36
1993 29
1994 31
1995 30
1996 36
1997 51
1998 37
1999 38
2000 49
2001 49
2002 42
2003 52
2004 61
2005 65
2006 67
2007 68
2008 65
2009 74
2010 94
2011 97
2012 91
2013 105
2014 100
2015 106
2016 143
2017 107
2018 121
2019 123
2020 103
2021 117
2022 123
2023 121
2024 96
2025 105
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,570 results

Results by year

Filters applied: . Clear all
Page 1
Syphilis vaccine: challenges, controversies and opportunities.
Ávila-Nieto C, Pedreño-López N, Mitjà O, Clotet B, Blanco J, Carrillo J. Ávila-Nieto C, et al. Among authors: blanco j. Front Immunol. 2023 Apr 6;14:1126170. doi: 10.3389/fimmu.2023.1126170. eCollection 2023. Front Immunol. 2023. PMID: 37090699 Free PMC article. Review.
Instructions for the use of L-PRF in different clinical indications.
Quirynen M, Blanco J, Wang HL, Donos N, Temmerman A, Castro A, Pinto N. Quirynen M, et al. Among authors: blanco j. Periodontol 2000. 2025 Feb;97(1):420-432. doi: 10.1111/prd.12564. Epub 2024 May 27. Periodontol 2000. 2025. PMID: 38803016 Free PMC article. Review.
Macrophage CD5L is a target for cancer immunotherapy.
Sanchez-Moral L, Paul T, Martori C, Font-Díaz J, Sanjurjo L, Aran G, Téllez É, Blanco J, Carrillo J, Ito M, Tuttolomondo M, Ditzel HJ, Fumagalli C, Tapia G, Sidorova J, Masnou H, Fernández-Sanmartín MA, Lozano JJ, Vilaplana C, Rodriguez-Cortés A, Armengol C, Valledor AF, Kremer L, Sarrias MR. Sanchez-Moral L, et al. Among authors: blanco j. EBioMedicine. 2023 May;91:104555. doi: 10.1016/j.ebiom.2023.104555. Epub 2023 Apr 11. EBioMedicine. 2023. PMID: 37054630 Free PMC article.
Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, Apea V, Boesecke C, Vandekerckhove L, Yakubovsky M, Sendagorta E, Blanco JL, Florence E, Moschese D, Maltez FM, Goorhuis A, Pourcher V, Migaud P, Noe S, Pintado C, Maggi F, Hansen AE, Hoffmann C, Lezama JI, Mussini C, Cattelan A, Makofane K, Tan D, Nozza S, Nemeth J, Klein MB, Orkin CM; SHARE-net Clinical Group. Thornhill JP, et al. Among authors: blanco jl. N Engl J Med. 2022 Aug 25;387(8):679-691. doi: 10.1056/NEJMoa2207323. Epub 2022 Jul 21. N Engl J Med. 2022. PMID: 35866746 Free article.
SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.
Sabadell-Basallote J, Astiarraga B, Castaño C, Ejarque M, Repollés-de-Dalmau M, Quesada I, Blanco J, Núñez-Roa C, Rodríguez-Peña MM, Martínez L, De Jesus DF, Marroquí L, Bosch R, Montanya E, Sureda FX, Tura A, Mari A, Kulkarni RN, Vendrell J, Fernández-Veledo S. Sabadell-Basallote J, et al. Among authors: blanco j. J Clin Invest. 2024 May 7;134(12):e173214. doi: 10.1172/JCI173214. J Clin Invest. 2024. PMID: 38713514 Free PMC article.
Mpox in people with advanced HIV infection: a global case series.
Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, Corral Herrera EA, Crabtree-Ramirez B, Blanco JL, Girometti N, Mazzotta V, Hazra A, Silva M, Montenegro-Idrogo JJ, Gebo K, Ghosn J, Peña Vázquez MF, Matos Prado E, Unigwe U, Villar-García J, Wald-Dickler N, Zucker J, Paredes R, Calmy A, Waters L, Galvan-Casas C, Walmsley S, Orkin CM; SHARE-NET writing group. Mitjà O, et al. Among authors: blanco jl. Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21. Lancet. 2023. PMID: 36828001
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial.
Ryan P, Blanco JL, Masia M, Garcia-Fraile L, Crusells MJ, Domingo P, Curran A, Guerri-Fernandez R, Bernal E, Bravo J, Revollo B, Macias J, Tiraboschi JM, Montejano R, Amador C, Torralba M, Merino D, Diaz-Brito V, Galindo MJ, Ferra S, Villoslada A, Losa JE, Fanjul FJ, Perez-Stachowski X, Peraire J, Portilla J, de la Fuente S, Dueñas C, Vazquez MJ, Di Gregorio S, Esteban H, Gil P, de Miguel M, Alejos B, Martínez E; PASO-DOBLE study group. Ryan P, et al. Among authors: blanco jl. Lancet HIV. 2025 Jul;12(7):e473-e484. doi: 10.1016/S2352-3018(25)00105-5. Epub 2025 Jun 7. Lancet HIV. 2025. PMID: 40489982 Clinical Trial.
2,570 results